New Biomarkers and Treatment Advances in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is a specific subtype of breast cancer lacking hormone receptor expression and HER2 gene amplification. TNBC represents a heterogeneous subtype of breast cancer, characterized by poor prognosis, high invasiveness, high metastatic potential, and a tendency to rela...

Descripción completa

Detalles Bibliográficos
Autores principales: El Hejjioui, Brahim, Lamrabet, Salma, Amrani Joutei, Sarah, Senhaji, Nadia, Bouhafa, Touria, Malhouf, Moulay Abdelilah, Bennis, Sanae, Bouguenouch, Laila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252475/
https://www.ncbi.nlm.nih.gov/pubmed/37296801
http://dx.doi.org/10.3390/diagnostics13111949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252475/
https://www.ncbi.nlm.nih.gov/pubmed/37296801
http://dx.doi.org/10.3390/diagnostics13111949

Ejemplares similares